CoChat

Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone

Zoppi, Giuseppe, Cinquetti, Mauro, Benini, Anna, Bonamini, Elettra, Minelli, Elisa Bertazzoni · 2001 · Current Therapeutic Research
Cited by 59

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Abstract Background: The value of oral bacteriotherapy during antibiotic treatment is a much debated subject. Comparative studies on the effects of different probiotics on the intestinal ecosystem are lacking. Objective: Six different commercially available preparations of probiotics and 1 prebiotic (lactulose) were compared to establish whether their action prevented or corrected imbalances in the intestinal ecosystem (dysbiosis) during parenteral therapy with ceftriaxone. Methods: Fifty-one children (25 female, 26 male; mean age, 5.1 years) admitted to the hospital for febrile respiratory tract infections were treated. Ceftriaxone 50 mg/kg per day was administered parenterally alone (therapy 1) or with 1 of the following probiotic/prebiotic preparations: Saccharomyces boulardii (therapy 2); Enterococcus species (therapy 3); lactulose (therapy 4); Lactobacillus casei GG (therapy 5); Lactobacillus rhamnosus, Lactobacillus bifidus , and Lactobacillus acidophilus (therapy 6); Bifidobacterium bifidum and L acidophilus (therapy 7); or a mixture of various lactobacilli and bifidobacteria at high concentrations (therapy 8). Intestinal microflora were evaluated by standard microbiologic methods and by biochemical assays on fecal samples collected before and after treatment. Results: Ceftriaxone induced a decrease in Escherichia coli and lactobacilli counts and an increase in cocci and clostridia counts. Partial protection of the intestinal ecosystem (eubiosis) was achieved with therapies 6, 7, and 8, which contained different combinations of Lactobacillus and Bifidobacterium species. Probiotics containing lactobacilli were more active than the older Saccharomyces and Enterococcus preparations. The newer probiotics reduced β-galactosidase, β-glucosidase, and β-glucuronidase levels. Increased fecal β-lactamase activity was observed in 60% of patients treated with ceftriaxone alone and 75% of those treated with ceftriaxone and S boulardii . A lower incidence of beta-lactamase-positive samples (30%–40%) was observed with therapy 7 and therapy 8. Conclusions: In this preliminary study, probiotics containing multiple species of lactobacilli and bifidobacteria administered at high concentration (20 billion to 360 billion per day) were more effective in preventing dysbiosis induced by ceftriaxone treatment than were other preparations studied. Probiotic therapy may need to be maintained for several days after discontinuation of antibiotic treatment to adequately restore balance to the intestinal ecosystem.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0011-393x(01)89006-8

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 59

Metadata

Authors
Zoppi, G., Cinquetti, M., Benini, A., Bonamini, E., & Minelli, E. B.
Venue
Current Therapeutic Research
Publisher
Elsevier BV
Published
2001-05
Volume
62
Issue
5
Pages
418-435
ISSN
0011-393X (ISSN-L)
OpenAlex
W1966342317
Cited by
59
References
1
FWCI
2.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. https://app.cochat.ai/papers/10.1016/s0011-393x(01)89006-8
The paper
Zoppi, G., Cinquetti, M., Benini, A., Bonamini, E., & Minelli, E. B. (2001). Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. Current Therapeutic Research. https://doi.org/10.1016/s0011-393x(01)89006-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.